Search:
 
Home > AIM > Company Profiles > AGI Therapeutics

Price

Market

Sector

Market Cap
45.75p (0.75p) 1.67% Up AIM Medicine and Biotech Research £30.84m
Add to company folder | Print
Articles Financial Data Charts Profile
Related Companies
AGY
 10.00p 0.00%
APH
 4.62p 0.00%
AZH
 p
BBI
 p
CEN
 p
CBF
 2.25p 0.00%
COT
 92.00p 0.00%
CRX
 2.75p 0.00%
CYX
 p
LAC
 p
EVC
 25.75p 0.00%
FUL
 3.00p 0.00%
FUM
 12.50p 0.00%
GMX
 1.75p -22.22% Down
GNI
 p
GWP
 29.00p -9.38% Down
HML
 0.45p 0.00%
MLR
 p
MMG
 6.75p 0.00%
MPM
 14.50p -4.92% Down

Commentary

Speciality pharmaceutical company focused on gastro-intestinal drug products

Recent Articles

New Issues Examined, by Oliver Haill 13/03/2006

Recent Announcements

Director Share Dealing
 15/09/2008
Interim Results
 09/09/2008
Notice of Results
 01/09/2008
Notification of Major Interes
 08/08/2008
Research Update
 18/07/2008
Research Update
 21/05/2008
AGI to present at DDW
 14/05/2008
Notice of AGM
 13/05/2008
Final Results
 03/04/2008
Research Update
 02/04/2008
More

Articles from the Sector

GW trims loss 19/11/2008
Asterand 18/11/2008
EU trial cheers Plethora 07/11/2008
IS Pharma 05/11/2008
Animalcare nurturing high-margin growth 03/11/2008
Phynova hails pre-clinical cheer 22/10/2008
e-Therapeutics 20/10/2008
Proximagen Neuroscience 16/10/2008
Tepnel expands with US deal 14/10/2008
Sinclair Pharma 03/10/2008
More

Financial History
Financial Year End 31/12/2004 31/12/2005 31/12/2006 31/12/2007
Currency EUR EUR EUR EUR
Turnover 0.00 0.00 0.20 0.39
Operating Profit -2.70 -4.60 -5.15 -15.41
Pretax Profit -3.12 -5.20 -4.18 -13.89
Earnings After Tax -3.12 -5.20 -4.32 -14.07
Profit Available For Dividend 0.00 0.00 0.00 0.00
Ordinary Dividends 0.00 0.00 0.00 0.00
Retained Profit 0.00 0.00 0.00 0.00
Shareholders Funds 1.06 -4.13 39.90 26.84
Net Current Assets 0.00 0.00 0.00 0.00
Adjusted Earnings Per Share Undiluted 0.00 0.00 0.00 0.00
Adj Earnings Per Share 0.00 0.00 0.00 0.00
Dividend Per Share 0.00 0.00 0.00 0.00

Company Details

Address Adelaide Chambers, Peter Street, Dublin, 8
Telephone +353 (0)1 449 3250
Fax +353 (0)1 449 3251

Executives

Chairman Ronan Lambe (2.10% holding)
Chief Executive John Devane (15.00% holding)
Finance Director David Kelly (0.80% holding)
Senior VP Bus. Develop. Patrick Ashe (2.40% holding)

Main Shareholders

ACT: 12.1%
Seroba: 6%
Delta: 6%
Bank of Ireland Asset Management

: 5.5%

Advisers

Nominated Adviser Piper Jaffray
Nominated Broker J&E Davy; Piper Jaffray
Solicitors Beauchamps
Auditors KPMG
Registrar n/a

Commentary

Speciality pharmaceutical company focused on gastro-intestinal drug products

Company Data
Code AGI
Sedol IE00B0YT0Q
Shares In Issue 67.413 m
Indices
Entry on AIM 27/02/2006
Interim Results Sep
Final Results Apr
Year End Dec
Accounts Due n/a
Int div payment n/a
Fin div payment n/a
Int net div per share nil
Fin net div per share nil
Probable CGT relief